Astrid Wiens

Astrid Wiens

Auto-generated profile, based on publicly available information

Astrid Wiens

Department of Pharmacy, Universidade Federal do Paraná, Curitiba, Brazil

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2016 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
DBDeise Regina Baptista
Deise Regina Baptista
AWAstrid Wiens
Astrid Wiens
RPRoberto Pontarolo
Roberto Pontarolo
LRLara Regis
Lara Regis
WRWalleri Christine Torelli Reis
Walleri Christine Torelli Reis
CCCassiano Januário Correr
Cassiano Januário Correr
The chronic care model (CCM) uses a systematic approach to restructure health care systems. The aim of this systematic review was to examine studies that evaluated different elements of the CCM in patients with type 2 diabetes mellitus (T2DM) and to assess the influence of the CCM on different clinical outcomes. There view was performed in the Medline and Cochrane Library electronic databases. The search was limited to randomized controlled trials conducted with T2DM patients. Studies were eligible for inclusion if they compared usual care with interventions that use done or more elements of the CCM and assessed the impact on clinical outcomes. After applying the eligibility criteria, 12 studies were included for data extraction. Of these, six showed evidence of effectiveness of the CCM for T2DM management in primary care as well as significant improvements in clinical outcomes. In the other six studies, no improvements regarding clinical outcomes were observed when comparing the intervention and control groups. Some limitations, such as a short follow-up period and a low number of patients, were observed. Some studies showed that the reorganization of health systems can improveT2DM care. However, it is possible that greater benefits could be obtained through combing all 6 elements of CCM.

1 July 2021 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
ACAlexandre de Fátima Fátima Cobre
Alexandre de Fátima Fátima Cobre
DSDILE PONTAROLO STREMEL
DILE PONTAROLO STREMEL
GNGuilhermina Rodrigues Noleto
Guilhermina Rodrigues Noleto
MFMariana Millan Fachi
Mariana Millan Fachi
MSMonica Surek
Monica Surek
RPRoberto Pontarolo
Roberto Pontarolo

5 November 2013 in BioDrugs
Verified
Journal Article
Closed access
PDF file
HBHelena Hiemisch Lobo Borba
Helena Hiemisch Lobo Borba
AWAstrid Wiens
Astrid Wiens
TSThais Teles de Souza
Thais Teles de Souza
CCCassyano Januário Correr
Cassyano Januário Correr
RPRoberto Pontarolo
Roberto Pontarolo

10 December 2015 in Molecules
Verified
Journal Article
Open access
PDF file
FTFernanda Tonin
Fernanda Tonin
LSLaiza M. Steimbach
Laiza M. Steimbach
AWAstrid Wiens
Astrid Wiens
CPCássio M. Perlin
Cássio M. Perlin
RPRoberto Pontarolo
Roberto Pontarolo
Background: Oxidative stress may lead to overproduction of reactive species and a decrease in antioxidant defenses, resulting in chronic diseases such as diabetes and cancer. The consumption of natural compounds with an antioxidant profile may be a preventive alternative. Therefore, we aimed to obtain evidence regarding the potential antioxidant activity of juices in human plasma. Methods: A systematic review and meta-analysis was performed, which included randomized controlled trials that compared the use of fruit or vegetable juices vs. placebo or other beverages. An electronic search was conducted in PubMed, Scopus, International Pharmaceutical Abstracts, and SciELO. The outcome measures extracted were related to antioxidant status, e.g., vitamin C, superoxide dismutase (SOD), and catalase (CAT) levels and reduction in malondialdehyde (MDA) and antioxidant capacity measured as TEAC. Results: Twenty-eight trials were identified (n = 1089), of which 16 were used for meta-analysis. No significant differences were observed between juices and placebo with regard to TEAC, SOD, and CAT. However, juices were superior to control in enhancing vitamin C and reducing MDA. Conclusions: Natural juices are possible candidates for the management of oxidative stress. The effects of juices should be further investigated by conducting larger and well-defined trials of longer duration.

1 February 2013 in Int. Journal of Clinical Pharmacology and Therapeutics
Verified
Journal Article
Closed access
Luana LenziLuana Lenzi
Luana Lenzi
AWAstrid Wiens
Astrid Wiens
RPRoberto Pontarolo
Roberto Pontarolo
Despite the effectiveness of highly active antiretroviral therapy (HAART), many adverse events (AEs) are associated with the use of these drugs, thus affecting treatment adherence. The aim of this study was to evaluate AE incidence with the use of HAART and the relationship to treatment adherence. This was a retrospective observational study conducted with patients who experienced serious AEs related to HAART, resulting in the need to change the therapeutic regimen. To calculate adherence, the dates the patients received HAART were used. From January 2009 to December 2011, 168 AE cases associated with antiretroviral drugs were observed. Of the total study population, 58% of the patients were male. The side effects were associated with 12 drugs, of which 58.3% were nucleoside analogues reverse transcriptase inhibitors (NRTIs). In addition, 16.7% were non-nucleoside reversetranscriptase inhibitors (NNRTIs), and 25% were protease inhibitors (PIs). The NRTIs and PIs presented similar numbers of AEs, whereas the NNRTIs resulted in less than 50% of the reported AEs compared to other drug classes. The low adherence observed in patients with severe AEs that force treatment regimen change suggests that the occurrence of side effects could be one of the obstacles affecting the adherence and thus the effectiveness of HAART.

1 October 2009 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
CCCassyano Januário Correr
Cassyano Januário Correr
RPRoberto Pontarolo
Roberto Pontarolo
AWAstrid Wiens
Astrid Wiens
PRPaula Rossignoli
Paula Rossignoli
AMAna Carolina Melchiors
Ana Carolina Melchiors
FFFernando Fernandez-Llimos
Fernando Fernandez-Llimos
OBJETIVO: Avaliar os resultados econômicos do seguimento farmacoterapêutico (SFT) em pacientes com diabetes melito tipo 2 em farmácias comunitárias privadas do sistema suplementar de Saúde. MÉTODOS: Foi realizado estudo clínico prospectivo com 161 pacientes separados em dois grupos, dos quais somente um recebeu SFT durante 12 meses. A partir dos resultados, foram calculados os dados de efetividade e os custos. O desfecho primário foi a avaliação econômica do SFT por meio da utilização de um indicador de efetividade (variação de hemoglobina glicada), relacionada aos custos do atendimento farmacêutico. Os desfechos secundários foram os valores de pressão arterial, circunferência abdominal e índice de massa corporal dos pacientes, que foram utilizados e relacionados a custos do atendimento do farmacêutico. RESULTADOS: Foi observada uma redução adicional de 1,3% da HbA1 no grupo que recebeu SFT em comparação ao grupo controle. Os custos anuais por paciente do grupo SFT relacionados à redução de 1% nos valores da HbA1 foram de R$ 78,83. Para melhoria no controle dos pacientes diabéticos tipo 2, esse recurso pode ser implementado com o investimento anual médio de R$ 456,05 por paciente, utilizando SFT e monitorização com testes de glicemia. CONCLUSÕES: É possível obter redução da HbA1 para níveis desejados por meio da utilização do SFT. Este pode ser considerado um recurso adicional para o alcance do controle metabólico, resultando, nesse estudo, em um custo de R$ 76,00 paciente/ano, para redução de 1% nos valores da HbA1.